Ignite Creation Date:
2025-12-24 @ 5:19 PM
Ignite Modification Date:
2026-01-04 @ 3:57 AM
Study NCT ID:
NCT00869050
Status:
COMPLETED
Last Update Posted:
2016-07-25
First Post:
2009-03-23
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Capecitabine and Temozolomide for Neuroendocrine Cancers
Sponsor:
Columbia University